Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma

Jin An; Ji Hyang Lee; Ha Kyeong Won; Yewon Kang; Woo Jung Song; Hyouk Soo Kwon; You Sook Cho; Hee Bom Moon; Tae Bum Kim

doi:10.1111/all.14084

Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma

Jin An, Ji Hyang Lee, Ha Kyeong Won, Yewon Kang, Woo Jung Song, Hyouk Soo Kwon, You Sook Cho, Hee Bom Moon, Tae Bum Kim

Research output: Contribution to journal › Letter › peer-review

33 Citations (Scopus)

Original language	English
Pages (from-to)	959-962
Number of pages	4
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	75
Issue number	4
DOIs	https://doi.org/10.1111/all.14084
Publication status	Published - 1 Apr 2020

Bibliographical note

Funding Information:
This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (2019M3E5D3073365).

Funding Information:
This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (2019M3E5D3073365).

Keywords

MRGPRX2
allergic asthma
biomarker
inhaled corticosteroid
prognosis

Access to Document

10.1111/all.14084

Cite this

@article{76ff6b63156148afa76ee9628d356391,

title = "Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma",

keywords = "MRGPRX2, allergic asthma, biomarker, inhaled corticosteroid, prognosis",

author = "Jin An and Lee, {Ji Hyang} and Won, {Ha Kyeong} and Yewon Kang and Song, {Woo Jung} and Kwon, {Hyouk Soo} and Cho, {You Sook} and Moon, {Hee Bom} and Kim, {Tae Bum}",

note = "Funding Information: This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (2019M3E5D3073365). Funding Information: This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (2019M3E5D3073365). ",

year = "2020",

month = apr,

day = "1",

doi = "10.1111/all.14084",

language = "English",

volume = "75",

pages = "959--962",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "4",

}

TY - JOUR

T1 - Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma

AU - An, Jin

AU - Lee, Ji Hyang

AU - Won, Ha Kyeong

AU - Kang, Yewon

AU - Song, Woo Jung

AU - Kwon, Hyouk Soo

AU - Cho, You Sook

AU - Moon, Hee Bom

AU - Kim, Tae Bum

N1 - Funding Information: This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (2019M3E5D3073365). Funding Information: This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (2019M3E5D3073365).

PY - 2020/4/1

Y1 - 2020/4/1

KW - MRGPRX2

KW - allergic asthma

KW - biomarker

KW - inhaled corticosteroid

KW - prognosis

UR - http://www.scopus.com/inward/record.url?scp=85074855875&partnerID=8YFLogxK

U2 - 10.1111/all.14084

DO - 10.1111/all.14084

M3 - Letter

C2 - 31605391

AN - SCOPUS:85074855875

SN - 0105-4538

VL - 75

SP - 959

EP - 962

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 4

ER -

Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma

Bibliographical note

Keywords

Access to Document

Other files and links

Cite this